E-CEL-CGT

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameE-CEL-CGT
Drug Alias NameE-CEL-CGT
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Hematopoietic stem cells therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHematologic Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAngiocrine Bioscience Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAngiocrine Bioscience Inc
Active IndicationsN/A
Inactive IndicationsHematologic Diseases

Other Information

ATC CodeN/A
Related LinksN/A